---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-24-000176"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2024-02-06T23:59:59+00:00"
generated_at: "2026-06-06T08:50:45.068207+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q4 net sales $221M, EPS $0.87; FY2023 sales -8%; FY2024 guidance $850-920M

## Summary
- Q4 net sales $221M (-3% YoY, +4% seq); diluted EPS $0.87 (+32% YoY).
- FY2023 net sales $921M (-8% YoY); diluted EPS $3.30 (-8% YoY).
- FY2024 guidance: net sales $850-920M, diluted EPS $2.40-3.00, down from FY2023.
- Greater China active customers +5% YoY, +11% seq; North Asia net sales -10% YoY.
- No share repurchases in Q4; $71M remaining authorization; cash $330M.

## SEC filing metadata
- accession: 0001157523-24-000176
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2024-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/0001157523-24-000176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/a53892955.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-24-000176
- JSON: https://secwatch.observer/filing/0001157523-24-000176.json
- Plain text: https://secwatch.observer/filing/0001157523-24-000176.txt

## Key facts
- Earnings Releases
  USANA HEALTH SCIENCES INC updated its the fourth quarter and fiscal year ended December 30, 2023 guidance (initiated).
  - Period: the fourth quarter and fiscal year ended December 30, 2023
  - Guidance: initiated
  - Result: reported results
  source text: On February 6, 2024, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000115752324000176/0001157523-24-000176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.